Pacifichealth Laboratories Stock Net Asset
PHLIDelisted Stock | USD 0.0001 0.00 0.00% |
PacificHealth Laboratories fundamentals help investors to digest information that contributes to PacificHealth Laboratories' financial success or failures. It also enables traders to predict the movement of PacificHealth Pink Sheet. The fundamental analysis module provides a way to measure PacificHealth Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PacificHealth Laboratories pink sheet.
PacificHealth |
PacificHealth Laboratories Company Net Asset Analysis
PacificHealth Laboratories' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current PacificHealth Laboratories Net Asset | 1.89 M |
Most of PacificHealth Laboratories' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PacificHealth Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, PacificHealth Laboratories has a Net Asset of 1.89 M. This is much higher than that of the Personal Products sector and significantly higher than that of the Consumer Staples industry. The net asset for all United States stocks is notably lower than that of the firm.
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
All Next | Launch Module |
PacificHealth Fundamentals
Return On Equity | -0.75 | ||||
Return On Asset | -0.25 | ||||
Profit Margin | (0.14) % | ||||
Operating Margin | (0.14) % | ||||
Current Valuation | 571.89 K | ||||
Shares Outstanding | 20.87 M | ||||
Price To Earning | (0.34) X | ||||
Price To Book | 0.71 X | ||||
Price To Sales | 0.07 X | ||||
Revenue | 6.91 M | ||||
Gross Profit | 2.99 M | ||||
EBITDA | (861.23 K) | ||||
Net Income | (486.31 K) | ||||
Cash And Equivalents | 324.48 K | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 54.86 K | ||||
Debt To Equity | 0.07 % | ||||
Current Ratio | 1.58 X | ||||
Book Value Per Share | 0.04 X | ||||
Cash Flow From Operations | (503.96 K) | ||||
Earnings Per Share | (0.04) X | ||||
Target Price | 2.8 | ||||
Beta | -275.06 | ||||
Market Capitalization | 87 | ||||
Total Asset | 1.89 M | ||||
Retained Earnings | (20.59 M) | ||||
Working Capital | 676 K | ||||
Current Asset | 1.84 M | ||||
Current Liabilities | 1.17 M | ||||
Z Score | -11.0 | ||||
Net Asset | 1.89 M |
About PacificHealth Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PacificHealth Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PacificHealth Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PacificHealth Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in PacificHealth Pink Sheet
If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |